EDWARD LEWIS: Open Payments
NPI 1831450774 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 14 payments from 8 companies in 2025. Trend: 2023 $1,109 · 2024 $697 · 2025 $1,482
Food & beverage: $1,482
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $337 |
| Teva Pharmaceuticals USA, Inc. | 2 | $248 |
| Alkermes, Inc. | 2 | $234 |
| Janssen Pharmaceuticals, Inc | 2 | $189 |
| Janssen Scientific Affairs, LLC | 2 | $128 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $115 |
| Neurocrine BioSciences, Inc. | 1 | $108 |
Products named: COBENFY, INVEGA SUSTENNA, LYBALVI, Auvelity, UZEDY, CAPLYTA, ARISTADA, INGREZZA.
Industry payments across SC — which companies pay providers there.
